1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:CVT characteristics among patients with dAVF and CVT diagnoses
dAVF and CVT (n = 55) Anatomic association of dAVF and CVT (n/N) (%) Probablea 45/55 (82) Possibleb 8/55 (15) Unlikelyc 2/55 (4) Time correlation of dAVF and CVT (n/N) (%) Previous CVT 4/55 (7) Concurrent CVT 33/55 (60) Subsequent CVT 18/55 (33) Following dAVF treatment 11/55 (20) Following conservative dAVF treatment 7/55 (13)